| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primary Health Care | 23 | 2025 | 769 | 3.640 |
Why?
|
| Substance-Related Disorders | 7 | 2024 | 480 | 3.200 |
Why?
|
| Family Practice | 11 | 2010 | 83 | 1.520 |
Why?
|
| Opioid-Related Disorders | 4 | 2025 | 296 | 1.510 |
Why?
|
| Anti-Bacterial Agents | 19 | 2025 | 2546 | 1.380 |
Why?
|
| Alcohol Drinking | 7 | 2017 | 343 | 1.370 |
Why?
|
| Complementary Therapies | 5 | 2014 | 44 | 1.360 |
Why?
|
| Urinary Tract Infections | 7 | 2025 | 328 | 1.350 |
Why?
|
| Vulnerable Populations | 3 | 2017 | 149 | 1.310 |
Why?
|
| United States | 48 | 2025 | 11827 | 1.300 |
Why?
|
| Patient Readmission | 4 | 2021 | 429 | 1.190 |
Why?
|
| Alcohol-Related Disorders | 4 | 2018 | 35 | 1.190 |
Why?
|
| Professional-Patient Relations | 3 | 2025 | 92 | 1.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2024 | 907 | 1.150 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 3 | 2014 | 11 | 1.140 |
Why?
|
| Adult | 57 | 2025 | 31127 | 1.050 |
Why?
|
| Intention | 2 | 2024 | 101 | 1.000 |
Why?
|
| Humans | 119 | 2026 | 130418 | 0.950 |
Why?
|
| Communication | 4 | 2025 | 531 | 0.930 |
Why?
|
| Vital Signs | 1 | 2025 | 23 | 0.920 |
Why?
|
| Health Promotion | 6 | 2016 | 408 | 0.890 |
Why?
|
| Health Behavior | 5 | 2023 | 388 | 0.870 |
Why?
|
| Mass Screening | 4 | 2024 | 805 | 0.860 |
Why?
|
| Buprenorphine | 3 | 2025 | 113 | 0.840 |
Why?
|
| Nonprescription Drugs | 3 | 2025 | 55 | 0.830 |
Why?
|
| Pediatric Obesity | 5 | 2018 | 412 | 0.810 |
Why?
|
| Female | 71 | 2025 | 70285 | 0.780 |
Why?
|
| Respiratory Tract Infections | 4 | 2013 | 293 | 0.780 |
Why?
|
| Papillomavirus Vaccines | 1 | 2024 | 110 | 0.750 |
Why?
|
| Phobic Disorders | 1 | 2022 | 40 | 0.750 |
Why?
|
| Panic Disorder | 1 | 2022 | 52 | 0.730 |
Why?
|
| Spinal Cord Injuries | 1 | 2025 | 273 | 0.730 |
Why?
|
| Yoga | 1 | 2021 | 12 | 0.700 |
Why?
|
| Meditation | 1 | 2021 | 19 | 0.690 |
Why?
|
| Tobacco Products | 1 | 2022 | 60 | 0.680 |
Why?
|
| Inpatients | 3 | 2020 | 550 | 0.680 |
Why?
|
| Middle Aged | 35 | 2025 | 28383 | 0.680 |
Why?
|
| Male | 56 | 2025 | 64527 | 0.670 |
Why?
|
| Language | 2 | 2023 | 216 | 0.660 |
Why?
|
| Treatment Refusal | 2 | 2020 | 79 | 0.650 |
Why?
|
| Opiate Alkaloids | 1 | 2020 | 3 | 0.640 |
Why?
|
| Amphetamines | 1 | 2020 | 8 | 0.640 |
Why?
|
| Smoking | 4 | 2022 | 923 | 0.640 |
Why?
|
| Cross-Sectional Studies | 17 | 2025 | 3803 | 0.640 |
Why?
|
| Family Health | 2 | 2018 | 242 | 0.630 |
Why?
|
| Patient Discharge | 3 | 2020 | 509 | 0.620 |
Why?
|
| Internship and Residency | 9 | 2025 | 1215 | 0.610 |
Why?
|
| Papillomavirus Infections | 1 | 2024 | 384 | 0.600 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2019 | 37 | 0.590 |
Why?
|
| Drug Prescriptions | 2 | 2018 | 230 | 0.590 |
Why?
|
| Tobacco Use Disorder | 1 | 2020 | 89 | 0.590 |
Why?
|
| Hospitalization | 6 | 2021 | 1927 | 0.580 |
Why?
|
| Primary Prevention | 2 | 2011 | 177 | 0.580 |
Why?
|
| Cocaine | 1 | 2020 | 209 | 0.560 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2018 | 22 | 0.560 |
Why?
|
| Health Care Costs | 3 | 2016 | 401 | 0.550 |
Why?
|
| Postpartum Period | 1 | 2020 | 230 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2017 | 1443 | 0.540 |
Why?
|
| Young Adult | 18 | 2024 | 9995 | 0.540 |
Why?
|
| Adjustment Disorders | 1 | 2017 | 5 | 0.530 |
Why?
|
| Health Transition | 1 | 2017 | 9 | 0.530 |
Why?
|
| Social Stigma | 1 | 2018 | 80 | 0.530 |
Why?
|
| Depression | 4 | 2024 | 1317 | 0.530 |
Why?
|
| Surveys and Questionnaires | 13 | 2026 | 4002 | 0.530 |
Why?
|
| Databases, Factual | 2 | 2020 | 1223 | 0.530 |
Why?
|
| Adolescent | 23 | 2024 | 20754 | 0.520 |
Why?
|
| Binge Drinking | 1 | 2017 | 10 | 0.520 |
Why?
|
| Cocaine-Related Disorders | 1 | 2019 | 205 | 0.520 |
Why?
|
| Counseling | 3 | 2020 | 237 | 0.510 |
Why?
|
| Pregnancy Complications | 2 | 2020 | 537 | 0.490 |
Why?
|
| Community Networks | 2 | 2013 | 30 | 0.490 |
Why?
|
| Cystitis | 3 | 2023 | 47 | 0.480 |
Why?
|
| Diabetes Complications | 1 | 2017 | 197 | 0.470 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 623 | 0.460 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2025 | 771 | 0.460 |
Why?
|
| Aged | 22 | 2025 | 20894 | 0.460 |
Why?
|
| Hospital Mortality | 2 | 2021 | 1065 | 0.460 |
Why?
|
| Telemedicine | 2 | 2023 | 511 | 0.450 |
Why?
|
| Urinalysis | 2 | 2025 | 74 | 0.450 |
Why?
|
| Prevalence | 9 | 2025 | 2685 | 0.440 |
Why?
|
| Personality Disorders | 1 | 2017 | 170 | 0.430 |
Why?
|
| Low Back Pain | 1 | 2014 | 41 | 0.420 |
Why?
|
| Pregnancy | 16 | 2024 | 7380 | 0.420 |
Why?
|
| Nursing Staff | 1 | 2013 | 12 | 0.410 |
Why?
|
| Education, Nursing, Continuing | 1 | 2013 | 21 | 0.410 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2013 | 15 | 0.410 |
Why?
|
| Family | 2 | 2016 | 579 | 0.410 |
Why?
|
| Healthcare Disparities | 2 | 2016 | 499 | 0.410 |
Why?
|
| Depressive Disorder | 1 | 2017 | 457 | 0.410 |
Why?
|
| Psychotherapy, Brief | 1 | 2014 | 53 | 0.400 |
Why?
|
| Exercise | 3 | 2016 | 859 | 0.400 |
Why?
|
| Oral Health | 1 | 2013 | 27 | 0.390 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 226 | 0.390 |
Why?
|
| Athletic Performance | 1 | 2013 | 14 | 0.390 |
Why?
|
| Preventive Health Services | 2 | 2015 | 59 | 0.390 |
Why?
|
| Dehydration | 1 | 2013 | 41 | 0.390 |
Why?
|
| Physicians, Primary Care | 2 | 2024 | 99 | 0.390 |
Why?
|
| Retrospective Studies | 18 | 2024 | 17614 | 0.380 |
Why?
|
| Community-Based Participatory Research | 1 | 2013 | 62 | 0.380 |
Why?
|
| Clostridium Infections | 1 | 2016 | 249 | 0.380 |
Why?
|
| Diet | 2 | 2017 | 1098 | 0.370 |
Why?
|
| Health Services Accessibility | 4 | 2026 | 693 | 0.370 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 451 | 0.370 |
Why?
|
| Fluid Therapy | 1 | 2013 | 147 | 0.360 |
Why?
|
| Texas | 6 | 2026 | 3626 | 0.350 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 646 | 0.350 |
Why?
|
| Self Care | 1 | 2013 | 226 | 0.350 |
Why?
|
| Croup | 1 | 2011 | 14 | 0.340 |
Why?
|
| Lepidoptera | 1 | 2011 | 3 | 0.340 |
Why?
|
| Foot Dermatoses | 1 | 2011 | 7 | 0.340 |
Why?
|
| Physicians, Family | 2 | 2002 | 37 | 0.340 |
Why?
|
| Health Status Disparities | 3 | 2025 | 275 | 0.330 |
Why?
|
| Managed Care Programs | 3 | 1999 | 55 | 0.330 |
Why?
|
| Obesity | 4 | 2022 | 2379 | 0.330 |
Why?
|
| Behavior Therapy | 1 | 2013 | 271 | 0.330 |
Why?
|
| Insect Bites and Stings | 1 | 2011 | 40 | 0.320 |
Why?
|
| Genital Diseases, Female | 1 | 2010 | 31 | 0.310 |
Why?
|
| Travel | 1 | 2011 | 127 | 0.310 |
Why?
|
| Universities | 3 | 2022 | 123 | 0.310 |
Why?
|
| Diabetes Mellitus | 4 | 2024 | 890 | 0.300 |
Why?
|
| Clinical Clerkship | 1 | 2010 | 70 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 877 | 0.290 |
Why?
|
| Alcoholism | 2 | 2025 | 244 | 0.290 |
Why?
|
| Bacteriuria | 2 | 2022 | 81 | 0.280 |
Why?
|
| Risk Factors | 12 | 2025 | 10942 | 0.280 |
Why?
|
| Curriculum | 5 | 2013 | 784 | 0.270 |
Why?
|
| Patient Education as Topic | 4 | 2025 | 456 | 0.260 |
Why?
|
| Narcotic Antagonists | 2 | 2018 | 110 | 0.260 |
Why?
|
| Peptic Ulcer | 2 | 1999 | 149 | 0.260 |
Why?
|
| Fibromyalgia | 1 | 2007 | 20 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2016 | 1051 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 2603 | 0.260 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 6781 | 0.250 |
Why?
|
| Drug Utilization | 5 | 2016 | 162 | 0.250 |
Why?
|
| MELAS Syndrome | 1 | 2007 | 34 | 0.250 |
Why?
|
| Socioeconomic Factors | 4 | 2017 | 889 | 0.240 |
Why?
|
| Body Mass Index | 4 | 2017 | 1676 | 0.240 |
Why?
|
| Phytotherapy | 2 | 2010 | 46 | 0.240 |
Why?
|
| Floods | 1 | 2026 | 22 | 0.240 |
Why?
|
| Public Health | 2 | 2022 | 272 | 0.240 |
Why?
|
| Stress, Psychological | 2 | 2024 | 544 | 0.230 |
Why?
|
| Program Evaluation | 2 | 2018 | 441 | 0.230 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 730 | 0.230 |
Why?
|
| Quadriplegia | 1 | 2025 | 35 | 0.230 |
Why?
|
| Inappropriate Prescribing | 1 | 2025 | 40 | 0.230 |
Why?
|
| Unnecessary Procedures | 1 | 2025 | 62 | 0.230 |
Why?
|
| DNA, Mitochondrial | 1 | 2007 | 232 | 0.230 |
Why?
|
| Opiate Substitution Treatment | 1 | 2025 | 45 | 0.230 |
Why?
|
| Guidelines as Topic | 2 | 2004 | 200 | 0.230 |
Why?
|
| Tennessee | 2 | 2016 | 34 | 0.230 |
Why?
|
| Evidence-Based Practice | 2 | 2018 | 115 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 701 | 0.220 |
Why?
|
| Paraplegia | 1 | 2025 | 87 | 0.220 |
Why?
|
| Child | 12 | 2024 | 26165 | 0.220 |
Why?
|
| Length of Stay | 3 | 2020 | 1395 | 0.220 |
Why?
|
| Louisiana | 6 | 2002 | 137 | 0.210 |
Why?
|
| Educational Status | 2 | 2025 | 274 | 0.210 |
Why?
|
| Infant, Newborn | 8 | 2022 | 8493 | 0.210 |
Why?
|
| Gammaproteobacteria | 1 | 2024 | 21 | 0.210 |
Why?
|
| Aging | 1 | 2011 | 1253 | 0.210 |
Why?
|
| Community Health Services | 2 | 2015 | 87 | 0.200 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 28 | 0.200 |
Why?
|
| Drug Industry | 1 | 2004 | 48 | 0.200 |
Why?
|
| Gift Giving | 1 | 2004 | 18 | 0.200 |
Why?
|
| Sex Factors | 6 | 2023 | 1334 | 0.200 |
Why?
|
| Electronic Mail | 1 | 2024 | 41 | 0.200 |
Why?
|
| Mortality | 3 | 2023 | 258 | 0.200 |
Why?
|
| Fatigue | 1 | 2024 | 195 | 0.200 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 1889 | 0.200 |
Why?
|
| Conflict of Interest | 1 | 2004 | 65 | 0.200 |
Why?
|
| Education, Distance | 1 | 2024 | 69 | 0.200 |
Why?
|
| Seat Belts | 2 | 2013 | 24 | 0.200 |
Why?
|
| Body Weight | 2 | 2018 | 984 | 0.200 |
Why?
|
| Quarantine | 1 | 2023 | 17 | 0.190 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2011 | 331 | 0.190 |
Why?
|
| Education, Medical, Continuing | 1 | 2004 | 130 | 0.190 |
Why?
|
| Institutional Practice | 1 | 2002 | 4 | 0.190 |
Why?
|
| Dyspnea | 1 | 2003 | 158 | 0.190 |
Why?
|
| Hospitals, Community | 1 | 2002 | 51 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 1543 | 0.180 |
Why?
|
| Physician-Patient Relations | 1 | 2025 | 435 | 0.180 |
Why?
|
| Global Health | 2 | 2017 | 626 | 0.180 |
Why?
|
| Papanicolaou Test | 1 | 2022 | 32 | 0.180 |
Why?
|
| Risk-Taking | 2 | 2013 | 94 | 0.180 |
Why?
|
| Pandemics | 3 | 2024 | 1153 | 0.170 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 2021 | 4 | 0.170 |
Why?
|
| Age Factors | 6 | 2021 | 2835 | 0.170 |
Why?
|
| Health Surveys | 2 | 2025 | 255 | 0.170 |
Why?
|
| Pregnancy Outcome | 3 | 2015 | 615 | 0.170 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 416 | 0.170 |
Why?
|
| Ethics, Medical | 1 | 2004 | 398 | 0.170 |
Why?
|
| Health Status | 3 | 2015 | 367 | 0.170 |
Why?
|
| Plants, Medicinal | 1 | 2000 | 23 | 0.170 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 318 | 0.160 |
Why?
|
| Neoplasms | 3 | 2021 | 2944 | 0.160 |
Why?
|
| Patient Dropouts | 1 | 2020 | 50 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 543 | 0.160 |
Why?
|
| Escherichia coli Infections | 1 | 2022 | 194 | 0.160 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 326 | 0.160 |
Why?
|
| Asphyxia | 1 | 2019 | 14 | 0.160 |
Why?
|
| Tobacco Use | 1 | 2020 | 29 | 0.150 |
Why?
|
| Pain Measurement | 2 | 2014 | 351 | 0.150 |
Why?
|
| Sudden Infant Death | 1 | 2019 | 37 | 0.150 |
Why?
|
| Self Medication | 1 | 2019 | 20 | 0.150 |
Why?
|
| Health Personnel | 1 | 2024 | 548 | 0.150 |
Why?
|
| Behavioral Medicine | 1 | 1999 | 11 | 0.150 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 1377 | 0.150 |
Why?
|
| Medical Staff, Hospital | 1 | 1999 | 95 | 0.150 |
Why?
|
| Acute Disease | 4 | 2017 | 1151 | 0.150 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 3 | 2024 | 43 | 0.150 |
Why?
|
| Mentoring | 1 | 2020 | 83 | 0.150 |
Why?
|
| Child, Preschool | 8 | 2018 | 14985 | 0.150 |
Why?
|
| Health Care Surveys | 2 | 2015 | 277 | 0.150 |
Why?
|
| Ciprofloxacin | 3 | 2024 | 63 | 0.150 |
Why?
|
| Multimorbidity | 1 | 2018 | 24 | 0.140 |
Why?
|
| Students | 1 | 2001 | 247 | 0.140 |
Why?
|
| Helicobacter pylori | 2 | 1999 | 1362 | 0.140 |
Why?
|
| Helicobacter Infections | 2 | 1999 | 1302 | 0.140 |
Why?
|
| Glaucoma | 1 | 1999 | 87 | 0.140 |
Why?
|
| Vaccination | 1 | 2024 | 1041 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2019 | 182 | 0.140 |
Why?
|
| Leadership | 1 | 2021 | 244 | 0.140 |
Why?
|
| Homicide | 1 | 2018 | 34 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3388 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 2000 | 233 | 0.140 |
Why?
|
| Hospitals | 2 | 2021 | 439 | 0.140 |
Why?
|
| Anxiety | 2 | 2022 | 1001 | 0.140 |
Why?
|
| Population Surveillance | 3 | 2019 | 396 | 0.140 |
Why?
|
| Culture | 1 | 2018 | 67 | 0.130 |
Why?
|
| Dysthymic Disorder | 1 | 2017 | 7 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 300 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2018 | 228 | 0.130 |
Why?
|
| Practice Management | 1 | 1997 | 4 | 0.130 |
Why?
|
| Education, Medical, Graduate | 2 | 1999 | 551 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 688 | 0.130 |
Why?
|
| Students, Medical | 1 | 2022 | 341 | 0.130 |
Why?
|
| Information Seeking Behavior | 1 | 2017 | 16 | 0.130 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2017 | 37 | 0.130 |
Why?
|
| Diagnosis-Related Groups | 1 | 2017 | 25 | 0.130 |
Why?
|
| Comorbidity | 3 | 2017 | 1587 | 0.130 |
Why?
|
| Access to Information | 1 | 2017 | 46 | 0.130 |
Why?
|
| Mammography | 2 | 2015 | 124 | 0.130 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 680 | 0.130 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 33 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2024 | 812 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 1997 | 113 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 1997 | 85 | 0.120 |
Why?
|
| Medical Overuse | 1 | 2016 | 24 | 0.120 |
Why?
|
| Asymptomatic Infections | 1 | 2016 | 39 | 0.120 |
Why?
|
| Rural Health | 1 | 1996 | 43 | 0.120 |
Why?
|
| Food Supply | 1 | 2017 | 91 | 0.120 |
Why?
|
| Enterobius | 1 | 1996 | 2 | 0.120 |
Why?
|
| Enterobiasis | 1 | 1996 | 3 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2024 | 840 | 0.120 |
Why?
|
| Cultural Competency | 1 | 2016 | 50 | 0.120 |
Why?
|
| Accidents, Occupational | 1 | 2015 | 9 | 0.110 |
Why?
|
| Total Quality Management | 1 | 2015 | 22 | 0.110 |
Why?
|
| Industry | 1 | 2015 | 28 | 0.110 |
Why?
|
| Homocysteine | 1 | 2015 | 116 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 1291 | 0.110 |
Why?
|
| Teaching | 1 | 1996 | 198 | 0.110 |
Why?
|
| Diabetic Foot | 1 | 1997 | 166 | 0.110 |
Why?
|
| Data Collection | 2 | 2010 | 366 | 0.110 |
Why?
|
| Contraindications | 1 | 2014 | 76 | 0.110 |
Why?
|
| Referral and Consultation | 2 | 2014 | 555 | 0.110 |
Why?
|
| Leukocytes | 1 | 2015 | 208 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 1996 | 207 | 0.110 |
Why?
|
| Catheter-Related Infections | 1 | 2016 | 137 | 0.110 |
Why?
|
| Diet Therapy | 1 | 2014 | 37 | 0.110 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 45 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5186 | 0.110 |
Why?
|
| Appendicitis | 1 | 1996 | 132 | 0.110 |
Why?
|
| Pharyngitis | 4 | 2024 | 34 | 0.110 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 169 | 0.110 |
Why?
|
| Telomere | 1 | 2015 | 219 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2015 | 175 | 0.100 |
Why?
|
| Weight Gain | 1 | 2016 | 380 | 0.100 |
Why?
|
| Cause of Death | 1 | 2016 | 503 | 0.100 |
Why?
|
| Southeastern United States | 1 | 2013 | 35 | 0.100 |
Why?
|
| Internet | 1 | 2017 | 418 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2017 | 465 | 0.100 |
Why?
|
| Parenting | 1 | 2018 | 345 | 0.100 |
Why?
|
| Qualitative Research | 3 | 2025 | 695 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 113 | 0.100 |
Why?
|
| Students, Nursing | 1 | 2013 | 24 | 0.100 |
Why?
|
| Veterans | 1 | 2025 | 1792 | 0.100 |
Why?
|
| Asthma | 1 | 2002 | 905 | 0.100 |
Why?
|
| Mothers | 1 | 2017 | 368 | 0.100 |
Why?
|
| Oral Hygiene | 1 | 2013 | 9 | 0.100 |
Why?
|
| Prognosis | 3 | 2011 | 4894 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2024 | 984 | 0.100 |
Why?
|
| Drinking | 1 | 2013 | 27 | 0.100 |
Why?
|
| Electrolytes | 1 | 2013 | 59 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2013 | 28 | 0.100 |
Why?
|
| Mutation | 1 | 2007 | 6131 | 0.100 |
Why?
|
| Waist Circumference | 1 | 2013 | 93 | 0.100 |
Why?
|
| Commerce | 1 | 2013 | 57 | 0.100 |
Why?
|
| Registries | 1 | 2020 | 1605 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2018 | 12860 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2015 | 406 | 0.090 |
Why?
|
| Guideline Adherence | 3 | 2016 | 391 | 0.090 |
Why?
|
| Sports | 1 | 2013 | 64 | 0.090 |
Why?
|
| Child Abuse | 1 | 2015 | 215 | 0.090 |
Why?
|
| Pain Management | 1 | 2014 | 204 | 0.090 |
Why?
|
| Hypertension | 1 | 2000 | 1352 | 0.090 |
Why?
|
| Florida | 3 | 2015 | 72 | 0.090 |
Why?
|
| Abruptio Placentae | 1 | 2011 | 14 | 0.090 |
Why?
|
| Focus Groups | 2 | 2025 | 232 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2017 | 5069 | 0.080 |
Why?
|
| Health Policy | 1 | 2013 | 223 | 0.080 |
Why?
|
| Placenta Previa | 1 | 2011 | 65 | 0.080 |
Why?
|
| Morbidity | 1 | 2011 | 259 | 0.080 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2010 | 4 | 0.080 |
Why?
|
| Premenstrual Syndrome | 1 | 2010 | 5 | 0.080 |
Why?
|
| Menstruation Disturbances | 1 | 2010 | 15 | 0.080 |
Why?
|
| Plant Preparations | 1 | 2010 | 15 | 0.080 |
Why?
|
| Epinephrine | 1 | 2011 | 143 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1419 | 0.080 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2010 | 31 | 0.080 |
Why?
|
| Larva | 1 | 2011 | 249 | 0.080 |
Why?
|
| Missouri | 4 | 2011 | 41 | 0.080 |
Why?
|
| Menopause | 1 | 2010 | 86 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2023 | 392 | 0.080 |
Why?
|
| Physician Executives | 1 | 2010 | 33 | 0.080 |
Why?
|
| Physical Examination | 2 | 2003 | 160 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2004 | 244 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1258 | 0.080 |
Why?
|
| Prenatal Care | 2 | 2009 | 341 | 0.070 |
Why?
|
| Infertility, Female | 1 | 2010 | 144 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2025 | 1452 | 0.070 |
Why?
|
| Physician's Role | 1 | 2010 | 165 | 0.070 |
Why?
|
| Health Education | 2 | 2001 | 226 | 0.070 |
Why?
|
| Poverty | 2 | 2025 | 450 | 0.070 |
Why?
|
| Stillbirth | 1 | 2008 | 105 | 0.060 |
Why?
|
| Heart Failure | 1 | 2000 | 2314 | 0.060 |
Why?
|
| Ethanol | 1 | 2008 | 164 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2009 | 254 | 0.060 |
Why?
|
| Incidence | 2 | 2021 | 3330 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2010 | 448 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 226 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 315 | 0.060 |
Why?
|
| Analgesics | 1 | 2007 | 120 | 0.060 |
Why?
|
| Survival Rate | 1 | 2011 | 2131 | 0.060 |
Why?
|
| Age Distribution | 1 | 2007 | 424 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2007 | 362 | 0.060 |
Why?
|
| Premature Birth | 1 | 2010 | 421 | 0.060 |
Why?
|
| Professional Competence | 2 | 2016 | 96 | 0.060 |
Why?
|
| Urine | 1 | 2025 | 91 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2007 | 169 | 0.060 |
Why?
|
| Quality of Life | 1 | 2015 | 2071 | 0.060 |
Why?
|
| Common Cold | 1 | 2024 | 24 | 0.050 |
Why?
|
| Employment | 1 | 2025 | 72 | 0.050 |
Why?
|
| Logistic Models | 3 | 2015 | 1799 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 328 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2008 | 1231 | 0.050 |
Why?
|
| American Medical Association | 1 | 2004 | 6 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2024 | 54 | 0.050 |
Why?
|
| Nitrofurantoin | 1 | 2023 | 10 | 0.050 |
Why?
|
| Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2003 | 9 | 0.050 |
Why?
|
| Health Literacy | 1 | 2024 | 75 | 0.050 |
Why?
|
| Workplace | 1 | 2024 | 82 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2003 | 890 | 0.050 |
Why?
|
| Infant | 5 | 2021 | 13269 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2003 | 108 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2024 | 93 | 0.050 |
Why?
|
| Medicare | 2 | 2010 | 438 | 0.050 |
Why?
|
| Overweight | 2 | 2017 | 376 | 0.050 |
Why?
|
| Biopsy | 1 | 2007 | 1239 | 0.050 |
Why?
|
| Antimicrobial Stewardship | 1 | 2024 | 87 | 0.050 |
Why?
|
| Mexico | 1 | 2023 | 188 | 0.050 |
Why?
|
| Demography | 1 | 2024 | 238 | 0.050 |
Why?
|
| Triage | 1 | 2003 | 144 | 0.050 |
Why?
|
| Diarrhea | 1 | 2024 | 312 | 0.050 |
Why?
|
| Pharmacists | 1 | 2023 | 102 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 308 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2007 | 853 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2002 | 136 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 33 | 0.040 |
Why?
|
| Career Mobility | 1 | 2022 | 51 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2022 | 113 | 0.040 |
Why?
|
| Hypertension, Renal | 1 | 2000 | 30 | 0.040 |
Why?
|
| Feedback | 1 | 2021 | 148 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 1005 | 0.040 |
Why?
|
| Accidents, Home | 1 | 2019 | 9 | 0.040 |
Why?
|
| Outpatients | 1 | 2022 | 266 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2001 | 116 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2011 | 269 | 0.040 |
Why?
|
| Intellectual Disability | 1 | 2007 | 1080 | 0.040 |
Why?
|
| Peer Group | 1 | 2020 | 122 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2025 | 3682 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 133 | 0.040 |
Why?
|
| Anti-Ulcer Agents | 1 | 1999 | 114 | 0.040 |
Why?
|
| Reference Values | 1 | 2000 | 678 | 0.040 |
Why?
|
| Gestational Age | 2 | 2015 | 1212 | 0.040 |
Why?
|
| Physicians | 1 | 2025 | 634 | 0.040 |
Why?
|
| Baltimore | 1 | 2018 | 44 | 0.040 |
Why?
|
| New York City | 1 | 2018 | 62 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2022 | 279 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 561 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 295 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1999 | 230 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1998 | 148 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2000 | 419 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1498 | 0.030 |
Why?
|
| Patient Selection | 1 | 2001 | 721 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2011 | 1215 | 0.030 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 731 | 0.030 |
Why?
|
| Tonsillitis | 1 | 1996 | 13 | 0.030 |
Why?
|
| Americas | 1 | 2016 | 51 | 0.030 |
Why?
|
| Ohio | 1 | 1996 | 87 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 250 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1996 | 84 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 29 | 0.030 |
Why?
|
| Colic | 1 | 1996 | 9 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 1125 | 0.030 |
Why?
|
| Evidence-Based Nursing | 1 | 2015 | 4 | 0.030 |
Why?
|
| Nurse Administrators | 1 | 2015 | 4 | 0.030 |
Why?
|
| Medical Staff | 1 | 2015 | 6 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 24 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2021 | 544 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 6190 | 0.030 |
Why?
|
| Perception | 1 | 2017 | 227 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 239 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2015 | 176 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 1996 | 154 | 0.030 |
Why?
|
| Vital Statistics | 2 | 2010 | 3 | 0.030 |
Why?
|
| Animals | 2 | 2011 | 33889 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1996 | 251 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2010 | 759 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 232 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 1482 | 0.020 |
Why?
|
| Minority Groups | 1 | 2015 | 258 | 0.020 |
Why?
|
| Life Style | 1 | 2015 | 445 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 146 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 426 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2010 | 45 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2010 | 78 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2015 | 698 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 256 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 2009 | 33 | 0.020 |
Why?
|
| Causality | 1 | 2009 | 90 | 0.020 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2009 | 60 | 0.020 |
Why?
|
| Placental Circulation | 1 | 2008 | 25 | 0.020 |
Why?
|
| Birth Weight | 1 | 2010 | 341 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 6423 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1616 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 1399 | 0.010 |
Why?
|
| Medicaid | 2 | 1997 | 251 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1680 | 0.010 |
Why?
|
| Endocarditis | 1 | 2003 | 103 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 1160 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3033 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2003 | 322 | 0.010 |
Why?
|
| HIV Infections | 1 | 2010 | 2013 | 0.010 |
Why?
|
| Kentucky | 1 | 1997 | 28 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 1125 | 0.010 |
Why?
|
| Rhinitis | 1 | 1997 | 42 | 0.010 |
Why?
|
| Cough | 1 | 1997 | 99 | 0.010 |
Why?
|
| Forecasting | 1 | 1997 | 353 | 0.010 |
Why?
|
| Social Class | 1 | 1997 | 206 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1997 | 937 | 0.010 |
Why?
|
| Lebanon | 1 | 1992 | 11 | 0.010 |
Why?
|
| Warfare | 1 | 1992 | 33 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1996 | 400 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1997 | 495 | 0.010 |
Why?
|